Healthcare News and Headlines
Healthcare News and Headlines
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Advocates have warned that the Centers for Medicare & Medicaid Services (CMS) and the Social Security Administration (SSA) have not yet issued public guidance on new Medicare eligibility restrictions targeting certain immigrant groups. The restrictions, embedded in the Republican‑led reconciliation bill, took effect immediately and are expected to strip Medicare coverage from thousands of eligible immigrants by next year. Without clear implementation instructions, providers and beneficiaries face confusion and potential loss of benefits. The agencies' silence has spurred calls for swift clarification to prevent disruptions in health‑care access.
Scientists have engineered silica‑based nanoparticles that encapsulate rifampicin and release it only when exposed to low‑frequency ultrasound. The ultrasound both propels the particles through the protective matrix of bacterial biofilms and triggers cavitation that opens the particles, delivering the antibiotic...
Vicarious Surgical announced it has filed an application to list its Class A common stock on Nasdaq, following a NYSE delisting notice earlier this month. Under new CEO Stephen From, the company has implemented cost‑cutting measures and outsourced parts of...
CMS Innovation Center Director Abe Sutton signaled a push to enroll more providers in mandatory ACO payment models. In interviews, ACO executives said mandatory models could significantly expand the reach of value‑based care, but their success hinges on how CMS...
GlaxoSmithKline replaced its Flovent HFA and Flovent Diskus inhalers with an identical authorized‑generic version priced substantially higher. The move was designed to sidestep Medicaid rebate requirements, prompting health plans and pharmacy benefit managers to erect new access hurdles. Senator Maggie...
Artificial intelligence is reshaping genomics by speeding up sequencing and uncovering patterns that traditional tools miss, enabling truly personalized medicine. AI models can predict disease risk, suggest optimal therapies, and guide tumor classification, especially in oncology and emerging mRNA vaccine...
The FDA has rebranded 21 CFR Part 820 as the Quality Management System Regulation (QMSR), effective February 2 2026, and formally incorporated ISO 13485:2016 by reference. The revision trims the regulation to only Subparts A (General Provisions) and B (Supplemental Provisions), directing manufacturers to the ISO standard...
Synergy Spine Solutions secured FDA pre‑market approval for its Synergy Disc, the first artificial cervical disc that simultaneously improves spinal alignment and preserves full range of motion. The device features a patented interrupted‑articulation geometry that creates a low‑energy, lordotic position...
Geographic atrophy (GA) management is poised to benefit from AI‑driven OCT analysis, which can quantify ellipsoid zone (EZ) loss, EZ‑RPE ratio, and EZ thickness with micron‑level precision. In Europe, imaging tools like the Topcon GA Monitor are approved, while the...
Heartflow announced that its AI‑enabled Plaque Analysis software will be highlighted in three ACC.26 presentations, showcasing data from a 15,000‑patient CCTA registry that predicts major adverse cardiovascular events. A separate DECIDE registry of nearly 3,800 patients demonstrated that AI‑guided care...
At HIMSS26, healthcare leaders highlighted the promise of agentic artificial intelligence to automate routine tasks such as prior authorizations, scheduling, and patient outreach. They warned that the technology’s independent decision‑making can introduce workflow risks if left unchecked. Effective deployment hinges...
The Democratic Republic of Congo is rapidly reshaping its health financing by mobilising domestic resources and tightening public financial management. Core health allocations now exceed 5.5 trillion Congolese franc, while new revenue streams – a 2 % import levy and a mandatory...
Structure Therapeutics announced positive topline data from its ACCESS II trial of aleniglipron, an oral small‑molecule GLP‑1 receptor agonist. The study demonstrated statistically significant reductions in HbA1c and weight loss comparable to injectable GLP‑1 therapies. Safety signals were mild, with few...
In 2022 32Co launched as a premium orthodontic aligner platform, then expanded in 2026 with Aerox Health, a dedicated sleep‑medicine brand. The company leveraged an existing dentist network to address the under‑served UK sleep‑apnoea market, applying the same clinical engine...
CytomX Therapeutics’ shares surged 66% after the company released expansion data from its Phase 1 study of Varseta‑M, a masked antibody‑drug conjugate targeting EpCAM in late‑stage colorectal cancer. The trial evaluated three dose levels, with the two highest doses achieving response...
Researchers have identified that a surface‑defensive molecule on cancer cells not only sends a “don’t‑eat‑me” signal but also conceals an “eat‑me” cue that would normally trigger immune clearance. A newly engineered antibody can disrupt this masking interaction, making tumors visible...
Jillian Romeo’s experience shows how young adults with cancer often face dismissed symptoms until disease advances. A 2024 analysis found 87% of adolescents and young adults had documented warning signs before diagnosis, with females waiting over three months on average....
A new JACC: Cardiovascular Interventions study of over 10,000 PCI patients in Japan found that heart‑failure hospitalizations occur in 4.7% of cases and are linked to a 25% two‑year mortality rate. By contrast, acute coronary syndrome and major bleeding showed...
Stryker, a leading medical‑device maker, suffered a wiper attack that used Microsoft Intune to remotely erase data on thousands of phones and workstations. The Iran‑linked Handala group claimed responsibility, alleging the theft of 50 TB of data and the destruction of...
A retrospective TriNetX analysis of 1,691 psoriasis patients compared bimekizumab with IL‑23 inhibitors and found no greater incidence of new‑onset depression, suicidal ideation, or related medication use. Over a two‑year follow‑up, the combined psychiatric event rate was 4.9% for bimekizumab...
After‑hours care remains a persistent gap in primary‑care delivery, with offices typically closed about 75 % of the day. The article argues that expanding capacity for both urgent and non‑urgent visits is essential to improve patient access without overloading clinicians. It...
Alvarez & Marsal’s MA Pulse Survey of 30 health‑system executives reveals a sharp inflection in Medicare Advantage participation, with declining reimbursements and rising denials eroding profitability. Six in ten respondents expect lower payments, while 74 % anticipate tougher collections and 52 % foresee...
A randomized, double‑blind study published in Mayo Clinic Proceedings found that a single 25 mg dose of off‑prescription Adderall caused significant acute increases in blood pressure and heart rate among healthy young adults. Systolic pressure rose by roughly 10 mm Hg, diastolic by...
The five‑year SOLVE‑TAVI trial shows that self‑expanding and balloon‑expandable transcatheter aortic valves deliver comparable long‑term efficacy and durability in both men and women with severe aortic stenosis. Stroke incidence was markedly lower in women receiving the self‑expanding valve (0.9% vs...
Kent and Medway Mental Health NHS Trust has added three digital tools to its electronic patient record (EPR) to capture peer support outcomes, including the Hope, Agency and Opportunity (HAO) measure, a dedicated peer‑support tab, and a specific SNOMED activity...
Modern electronic health records now contain years of notes, labs, imaging and messages, creating a “storage unit” that clinicians cannot fully review in the few minutes before a visit. This overload forces doctors to perform a real‑time “chart biopsy,” often...
Six biotech firms are pushing next‑generation prostate‑cancer therapies through late‑stage trials and financing milestones. Candel Therapeutics secured a $100 million royalty deal to fund aglatimagene’s launch, while Coherus Oncology closed a $50.1 million offering and partnered with J&J for a CCR8 antibody...
CMS head Mehmet Oz convened leaders of the American Medical Association, American Psychiatric Association and American Society of Plastic Surgeons for a closed‑door meeting on transgender medical care for adolescents. While the AMA and APA reaffirmed support for hormone therapy,...
The medical services sector is being reshaped by rapid digital‑health adoption and a booming healthcare analytics market valued at $30.33 billion with a 28.2% CAGR through 2034. A persistent workforce shortage—projected at 100,000 vacant positions by 2028, especially 73,000 nursing‑assistant roles—pressures...
Homecare Homebase (HCHB) unveiled Curate: Scribe, an AI‑assisted documentation tool built into its EHR. Developed with StenoHealth, the feature generates draft clinical notes that clinicians can review and edit, aiming to cut the time spent on paperwork. By embedding AI...
Ethermed and VisiQuate announced a strategic partnership that merges Ethermed’s embedded prior‑authorization automation with VisiQuate’s AI‑driven predictive models, data engine, and robotic process automation. The combined platform predicts authorization requirements, executes submissions directly within clinical workflows, and continuously refines its...
Women’s health funding has exploded, with investment rising over 300% since 2018 and tripling again by 2024, reflecting a clear market opportunity. Yet commercialization lags, leaving startups unable to scale, patients facing delayed access, and revenue potential unrealized. Fragmented care...
The Bureau of Labor Statistics reported that total non‑farm payrolls fell by 92,000 jobs in February, with health‑care employment shrinking by 28,000 jobs after a wave of worker strikes. Despite the dip, the health‑care sector has added an average of...
Elevara Medicines has dosed the first patient in its phase 2b START‑SYNERGY trial, testing the oral CDK4/6 inhibitor ELV001 in rheumatoid arthritis patients who have failed methotrexate and TNF inhibitors. The randomized, placebo‑controlled study will enroll about 180 participants across nine...
Researchers at the University of Illinois Urbana‑Champaign have engineered a photonic‑nanomaterial platform that senses microRNA and DNA signatures linked to cancer up to five to eight years before conventional diagnostics can. The system leverages photonic crystal grating resonance and nano‑assemblies...
A multicenter retrospective cohort of nearly 15,000 low‑risk adults showed that 80% of patients with Lipoprotein(a) above 50 mg/dL did not start any lipid‑lowering medication within 90 days of testing. Initiation of statins was modest, while use of PCSK9 inhibitors and...
Cir‑Code Bio‑med, a Chinese biotech focused on circular RNA medicines, has secured an Investigational New Drug (IND) approval from the U.S. Food and Drug Administration to commence its first human trial. The therapy targets a rare genetic disorder using a...
Physicians are adopting minimally invasive tools like radiofrequency ablation (RFA) to treat benign thyroid nodules, reducing the need for surgery and preserving gland function. Enhanced diagnostics—including high‑resolution ultrasound and comprehensive hormone panels—are improving accuracy and enabling data‑driven treatment adjustments. Integrating...
Oxford Medical Simulation (OMS) has secured €5.78 million in growth funding from Salica Investments. The capital will fund OMS’s expansion into U.S. health systems and universities, and accelerate product innovation such as AI‑driven scenarios, learning analytics, and workflow tools. The round...
Bayer’s 2018 acquisition of Monsanto brought a wave of glyphosate lawsuits, prompting a proposed $7.25 billion class settlement and an undisclosed additional pact. The company’s CEO, Bill Anderson, is steering a restructuring that includes 12,000 layoffs and a focus on pharma...
The Professional Standards Authority has announced it will support the General Medical Council’s appeal of the Medical Practitioners Tribunal Service’s decision that cleared Dr Ghassan Abu‑Sitta of terrorism‑related misconduct. The appeal follows a petition signed by thousands of doctors demanding the...
Structure Therapeutics announced that its daily oral GLP‑1 obesity pill produced an average 16% body‑weight reduction versus placebo after 44 weeks in a Phase 2 trial. The result outperforms Eli Lilly’s orforglipron, which showed about 11% loss over 72 weeks, and rivals...
Havas Life London’s new report reveals that stigma is a pervasive, structural barrier in rare disease care, affecting 89% of patients and caregivers surveyed. Healthcare settings account for the largest share of stigma incidents, with 42% reporting dismissed symptoms and...
Structure Therapeutics released Phase 2 data for its oral GLP‑1 agonist, positioning the candidate as a next‑generation alternative to injectable therapies from Eli Lilly and Novo Nordisk. The trial demonstrated a mean 30% reduction in HbA1c and 70% of participants achieving target...
The Atlantic outlines a surge in off‑label and experimental peptide use, noting that Vyleesi—approved for women’s hypoactive sexual desire disorder—is being bought by men through “research use only” listings and online pharmacies. Compounding pharmacies and telehealth firms now market customized...
The American College of Radiology’s 2025 Intersociety Meeting produced ten actionable solutions to halt the erosion of academic radiology’s core mission of patient care, education, and research. Experts cite practice consolidation, rising imaging volumes and burnout as primary threats. Recommendations...
The FDA is accelerating the shift of prescription medicines to over‑the‑counter status, highlighted by Commissioner Marty Makary’s call for broader OTC availability and the introduction of the Additional Condition for Non‑Prescription Use (ACNU) framework. Former FDA counsel Heidi Gertner stresses...
A new qualitative study in BMC Geriatrics reveals the intense psychological, physical, and social pressures faced by family caregivers of late‑stage dementia patients. Interviews expose high rates of depression, anxiety, and burnout, compounded by fragmented health‑care navigation and dwindling social...
Mike Schultz retired from Paralympic snowboarding after winning a bronze in the Cortina banked slalom, capping a career that includes four medals and two golds. He is celebrated for designing the BioDapt prosthetic knee and foot that now equip every...
Santa Cruz‑based Unnatural Products secured a $45 million Series B round to accelerate its macrocycle drug platform. The financing follows a newly announced partnership with Novartis that will grant the pharma giant early access to the company’s pipeline and a co‑development option...
